Impact of COVID-19 Infection During Pregnancy
1 other identifier
observational
65
1 country
1
Brief Summary
To asses impact of the COVID-19 infection during Pregnancy on maternal and fetal outcome in relation to gestational age.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2021
CompletedFirst Submitted
Initial submission to the registry
November 29, 2021
CompletedFirst Posted
Study publicly available on registry
December 1, 2021
CompletedDecember 1, 2021
November 1, 2021
1.2 years
November 29, 2021
November 29, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Studying impact of COVID-19 on pregnancy
understanding of the impact of COVID-19 on pregnancy will provide critical data about the course of the disease in pregnant women and their infants .
baseline
Interventions
No intervention
Eligibility Criteria
All medical records of pregnant women admitted to EL Bagour Quarantine hospital, Menoufia governorate diagnosed with SARS-CoV-2 infection from May, 2020 were revised to collect maternal and neonatal data using a standardized data collection sheet. The Information included: * Age * GA * Parity * Pre-existing medical condition * Presenting symptoms at admission; such as fever, sore throat/ nasal or sinus congestion, cough/chest pain, vomiting/diarrhea, and fatigue/myalgia, dyspnea….etc. * Body mass index. * The laboratory results at admission and on discharge * Lymphopenia was defined when lymphocytes count less than 1100 cells/mm3. * Ultrasound report upon admission to the hospital that included; fetal viability, amniotic fluid index and any placental abnormality. * C.T. Report if done.
You may qualify if:
- All medical records of the pregnant women admitted to EL Bagour Quarantine hospital, Menoufia governorate due to SARS-CoV-2 infection, as confirmed by real-time reverse transcriptase-polymerase chain reaction (RT-PCR) assay of nasopharyngeal swab specimens.
You may not qualify if:
- Patients who had equivocal or negative testing results were excluded from the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Menoufia University hospital
Shibīn al Kawm, Menoufia, 11111, Egypt
Study Officials
- STUDY DIRECTOR
Mohamed E Anter, MD
Menoufia University-Shebin Elkom-Egypt
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor of obstetrics and gynecology
Study Record Dates
First Submitted
November 29, 2021
First Posted
December 1, 2021
Study Start
May 1, 2020
Primary Completion
July 31, 2021
Study Completion
July 31, 2021
Last Updated
December 1, 2021
Record last verified: 2021-11